Concepedia

Gary Lu

GL

33

Publications

1.7K

Citations

21

H-Index

2001

Active since

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Rutgers, The State University of New Jersey

Huazhong University of Science and Technology

The University of Texas Health Science Center at Houston

Gary Lu is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, pathology, and oncology.

Top concepts

Publications per year

2001–2022

33

Publications

33

Pembrolizumab versus placebo as post-nephrectomy adjuvant therapy for clear cell renal cell carcinoma (KEYNOTE-564): 30-month follow-up analysis of a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

Thomas Powles, Piotr Tomczak, Se Hoon Park et al. · The Lancet Oncology · 2022 · 262 citations · Full text

Pro-oxidative activities and dose–response relationship of (−)-epigallocatechin-3-gallate in the inhibition of lung cancer cell growth: a comparative study in vivo and in vitro

Guang-Xun Li, Yu‐Kuo Chen, Zhé Hóu et al. · Carcinogenesis · 2010 · 237 citations · Full text

Molecular characterization of<i>de novo</i>Philadelphia chromosome-positive acute myeloid leukemia

Sergej Konoplev, C. Cameron Yin, Steven M. Kornblau et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2012 · 115 citations

Preoperative prediction for pathological grade of hepatocellular carcinoma via machine learning–based radiomics

Bing Mao, Lianzhong Zhang, Peigang Ning et al. · European Radiology · 2020 · 113 citations

, , +13

Population-based, case-control study of blood C-peptide level and breast cancer risk.

Gong Yang, Gary Lu, Fan Jin et al. · PubMed · 2001 · 78 citations

, , +18

Rows per page

1–5 of 33